BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37218321)

  • 1. [Ⅳ. Advances in Diagnosis and Treatment of Vitreoretinal Lymphoma].
    Taoka K
    Gan To Kagaku Ryoho; 2023 May; 50(5):605-610. PubMed ID: 37218321
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge in the diagnosis and management of vitreoretinal lymphoma.
    Habot-Wilner Z; Pe'er J; Frenkel S
    Clin Exp Ophthalmol; 2023 Mar; 51(2):107-109. PubMed ID: 36789671
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Rie Tanaka et al.'s "Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results".
    Zhang X; Zhang Y; Zhang W; Zhang M
    Ocul Immunol Inflamm; 2023 Jul; 31(5):1111. PubMed ID: 35998315
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary intraocular lymphoma: A review.
    Choi JY; Kafkala C; Foster CS
    Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
    Rajagopal R; Harbour JW
    Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular tumour balls in primary vitreoretinal lymphoma.
    Takkar B; Rathi A; Gaur N; Kumar A
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567275
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of Intraretinal Infiltration of Vitreoretinal Lymphoma.
    Gu J; Zhang K; Chang Q
    Ophthalmol Retina; 2023 Nov; 7(11):998. PubMed ID: 37462594
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitreoretinal lymphoma: an alternative view.
    Damato B
    Eye (Lond); 2022 Sep; 36(9):1845. PubMed ID: 34795414
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraocular lymphoma: more questions than answers.
    Wakefield D; Zierhut M
    Ocul Immunol Inflamm; 2009; 17(1):6-10. PubMed ID: 19294566
    [No Abstract]   [Full Text] [Related]  

  • 11. Who Is Who in Primary Vitreoretinal Lymphoma?
    Ferreri AJ
    JAMA Oncol; 2015 Oct; 1(7):977-8. PubMed ID: 26181757
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid-induced delayed diagnosis of primary vitreoretinal lymphoma with ghost brain tumor: A case report.
    Kau HC; Wang CJ; Tsai CC
    Medicine (Baltimore); 2022 Jul; 101(29):e29637. PubMed ID: 35866822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of primary vitreoretinal lymphoma developing extra-central nervous system (CNS)/testicular lymphomas with or without CNS involvement: A single-centre study of 13 cases.
    Kunimi K; Usui Y; Sugawara R; Asakage M; Tsubota K; Gotoh A; Goto H
    Br J Haematol; 2023 Apr; 201(1):158-161. PubMed ID: 36693806
    [No Abstract]   [Full Text] [Related]  

  • 14. The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal Lymphoma.
    Stacey AW; Pulido JS
    Retina; 2020 Jul; 40(7):1213-1214. PubMed ID: 32404846
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
    Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
    Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma in immunoprivileged sites: association of vitreoretinal, testicular and central nervous system lymphoma.
    Riemens A; Missotten T; Baarsma S; Vidovic-Valentincic N; Novac-Andrejcic K; Erckens R; Kuijpers R; Lokhorst H; Rothova A
    Acta Ophthalmol; 2014 Mar; 92(2):e159-60. PubMed ID: 23819861
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
    Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
    Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Therapy of Vitreoretinal Lymphoma: Local Therapy Has Palliative Effect.
    Singh AD
    Ophthalmol Retina; 2024 Apr; 8(4):315-316. PubMed ID: 38580415
    [No Abstract]   [Full Text] [Related]  

  • 20. Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.
    Baron M; Belin L; Cassoux N; Fardeau C; Blaizeau M; Soussain C; Houillier C; Hoang-Xuan K; Gyan E; Le Lez ML; Lavaud A; Soubeyran P; Bodaghi B; Costopoulos M; Leblond V; Touitou V; Maloum K; Errera MH; Roos-Weil D; Le Garff-Tavernier M; Choquet S
    Blood; 2020 May; 135(20):1811-1815. PubMed ID: 32125361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.